Korean J Urol.  1980 Oct;21(5):418-425.

A Clinical Obervation on the Sarcoma of Bladder and Prostate

Affiliations
  • 1Department of Urology, College of Medicine, Seoul National University, Seoul, Korea.

Abstract

Sarcoma of prostate and bladder is rare malignant disease and its prognosis is very poor because of rapid growing tendency. Recently the combined treatment of surgery, radiotherapy and chemotherapy has increased the survival rate, significantly A clinical observation and retrospective analysis were made on 9 patients with primary sarcoma of bladder and prostate which were admitted during the period of 8 years and 8 months from January. 1971 to August, 1979. The results obtained were as follows: 1. The age distribution ranged from 2 years to 51 years and the prostate sarcoma was most common in the young age group upto 15 years. 2. The presenting symptoms were dysuria in 6 patients (67%), acute urinary retention in 4 patients(44%), hematuria in 3 patients(33%), frequency in 2 patients(22%), G-I symptoms were also noticed in 4 patients(44%). 3. The histologic types were 6 rhabdomyosarcoma. 1 leiomyosarcoma, 1 liposarcoma and 1 lymphoma. 4. Among 2 cases in which metastasis was confirmed, lung and liver were the sites of metastasis in a prostate rhabdomyosarcoma and the cervical lymph node in a bladder lymphoma. 5. Four patients of 9 prostate and bladder sarcomas were treated with surgery and/or chemotherapy and/or radiotheraphy. Of these, 1 patient is alive 4 months since surgery to date, 2 patients died within l year and 1 patients is presumed dead.

Keyword

sarcoma; bladder; prostate

MeSH Terms

Age Distribution
Drug Therapy
Dysuria
Hematuria
Humans
Leiomyosarcoma
Liposarcoma
Liver
Lung
Lymph Nodes
Lymphoma
Neoplasm Metastasis
Prognosis
Prostate*
Radiotherapy
Retrospective Studies
Rhabdomyosarcoma
Sarcoma*
Survival Rate
Urinary Bladder*
Urinary Retention
Full Text Links
  • KJU
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr